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1 INTRODUCTION 
During embryo implantation and haemochorial placentation trophoblast cells interact 
both with the endometrial stroma and the uterine spiral arteries [5], Both processes represent 
a biological paradox which cannot be explained easily with our present knowledge of cell 
biology [46], The biochemical and physical duet of the mother and the fetus in the formation 
of the placenta is one of the most carefully orchestrated phenomena in fetal development. It 
represents the cooperation of two distinct individuals to form a single structure that protects 
one and enables the genes of the other to live on. This example of evolution at its finest 
involves a highly regulated balance between trophoblast proliferation, motility, change in 
adhesive properties and differentiation [3], 
Placental development, which ultimately brings maternal and fetal circulation in close 
proximity to each other, starts with the process of implantation [132]. The uterus of almost all 
mammals is ready for implantation only during a limited period of time (implantation 
window) [124], Before or after this period the uterus is either indifferent or hostile to the 
embryo. The period during which an embryo is capable of implanting is usually much longer 
but varies considerably from species to species. The absolute necessity of a sinchronization 
between embryonic and uterine development is the most important limitation of the otherwise 
evident evolutionary advantage of viviparity. 
In humans, implantation is interstitial and antimesometrial: the embryo implants 
deeply in the body of the uterus, most frequently in the upper part of the posterior wall near 
the mid sagittal plane [25]. In all mammals, including humans, the implantation process can 
be divided in two phases: an attachment phase and a penetration phase. 
During the attachment phase the blastocyst first "finds" its implantation site and then 
anchors itself to the apical surface of the uterine epithelium. In humans, the attachment of the 
blastocyst to the uterine lining via its embryonic pole usually occurs on the 6 or the 7th day 
after fertilization [110], From a biological point of view this process consists of two distinct 
steps: apposition and adhesion. During apposition, no visible connections are established 
between the blastocyst and the endometrium, and the blastocyst can be dislodged easily by 
simple washing of the uterine cavity. In contrast, adhesion is the step during which functional 
connections are established although the nature of these connections is still very speculative. 
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Thought to play a role are carbohydrate lectin interactions, stabilized by binding of integrins 
to their extracellular matrix ligands. Trophoblasts also express proteoglycans and other 
carbohydrate structures thought to be critical in binding [40]. 
After initial attachment of the embryo to the uterine lining, the outer cell layer of the 
blastocyst, consisting of mononuclear trophectodermal cells that surround the inner cell mass, 
give rise to a second population of cells that divide in the absence of cytokines. They form a 
multinucleated STB [58] which surrounds the entire embryo, and forms projections which 
progress between the adjacent endometrial epithelial cells to reach the underlying basement 
membrane. At this point trophoblast pauses at the residual basal lamina of the uterine luminal 
epithelium before progressing into the endometrial stroma [132], After crossing the basement 
membrane trophoblast cells invade the uterine stroma and finally breach the wall of maternal 
blood vessels (Fig. 1.). Concomitantly, the remaining unfused trophectodermal cells 
(e.g. mononuclear CTBs) spread along the basement membrane to form the trophoblastic 
plate [31]. 
At eight days after ovulation the blastocyst is completely embedded in the uterine 
stroma and the site of entry is covered by fibrin over which the uterine epithelial cells grow. 
During the second week of gestation, proliferating CTBs form primary villi, which are 
trabeculae of mononuclear cells covered by a layer of syncytium, interposed between the 
fluid-filled, and later maternal blood-filled lacunae formed in the multinucleated mass of the 
invading STB. The extraembryonic mesoderm begins to project into these structures 
Figure 1. Schematic representation of a human 
implantation site at approximately nine days 
after conception (adapted from [3]). The outer 
layer of the embryo consists of 
syncytiotrophoblast. Adjacent to the outer 
syncytiotrophoblast surface, at its interface with 
the maternal uterine stroma, is a zone of tissue 
degradation. Beneath the syncytium is the CTB 
layer. 
Legend: CTB - cytotrophoblast 
STB - syncytiotrophoblast 
UE - uterine epithelium 
US - uterine stroma 
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transforming them into secondary villi. When blood vessels begin to enter the mesodermal 
core, the villus is known as tertiary villus (Fig. 2.) By the third week of pregnancy, the newly 
formed tertiary villi undergo branching, increasing the surface area of the chorion that is 
exposed to maternal blood. The villous tree undergoes stromal alterations and remodeling 
leading to the formation of different types of villi throughout pregnancy [14, 32], The mature 
villi (Fig. 3.) consist of an outer syncytial layer and an inner layer of CTB cells surrounding 
the fetal stroma which contains blood vessels [25]. 
Figure 2. Schematic diagram of the placenta at the end of first trimester showing various trophoblast 
subpopulations (adapted from [86]). Anchoring villi serve to maintain the attachment of the placenta to the 
uterine wall. Extravillous trophoblast cells migrate out of the tips of anchoring villi initially as cell columns, and 
then form the cytotrophoblastic shell, an organized cell layer or become dispersed within the decidua as isolated 
interstitial trophoblast cells which are highly invasive. Other extravillous trophoblast cells invade uterine 
vessels, replacing the endothelium. Some extravillous trophoblast cells can invade as far as the myometrium, 
while others fuse in the decidua to form placental bed giant cells which are presumably noninvasive. 
Legend: AV - anchoring villus; CV - chorionic villus; CS - cytotrophoblastic shell; DC - decidual cells; EVT -
extravillous trophoblast; GC - giant cells; UE - uterine epithelium; U V - uterine blood vessels 
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villus 
CTB 
Figure 3. Schematic representation of the materno-fetal interface approximately four weeks after fertilisation, 
showing the tip of a placental anchoring villus and the adjacent placental bed (adapted from [3]) 
Legend: CTB - cytotrophoblast; D - decidua; ivs - intervillous space; STB - syncytiotrophoblast 
Three major trophoblast populations can be identified during placentation: CTB stem 
cells and two differentiated derivative cell types - the STB and the extravillous CTB [153]. 
The undifferentiated trophoblastic stem cell of the placenta, the CTB cell, is the first fetal cell 
type arising during embryogenesis. It derives from the external trophectodermal cell layer of 
the blastocyst, thus it is extraembryonic in origin. It represents the earliest epithelium and 
forms a variety of different structures e.g., placental villi and fetal membranes [14]. Just as 
the undifferentiated basal layer of the skin gives rise to differentiated keratinocytes, the CTB 
stem cell of the placenta undergoes a multistep differentiation and finally gives rise to villous 
(non-invasive) and extravillous (invasive) trophoblast cell populations [160, 162] (Fig. 4.). 
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Figure 4. Scheme of human trophoblast differentiation (adapted from [3]) 
Legend: filled arrows - established pathways; broken arrows - possible minor pathways; unlabeled arrows -
intrinsic differentiation pathways; labeled arrows: A - short-range (decidual) stimulus; B - maternal vascular 
stimulus; P - proliferating cells; * - cells active in remodeling the maternal tissue environment; X - cells 
exhibiting prominent motile activity; thick brackets - terminus of a pathway; CTB - cytotrophoblast; 
STB - syncytiotrophoblast 
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Figure 5. Diagram of a longitudinal section of an anchoring chorionic villus at the fetal-maternal interface at 
approximately 10 weeks gestational age (adapted from [164]). The anchoring villus functions as a bridge 
between the fetal and maternal compartments, whereas floating villi are suspended in the intervillous space and 
are bathed by maternal blood. CTB in anchoring villi (Zone I) form cell columns (Zones II and III). CTB then 
invade the uterine interstitium - decidua and first third of the myometrium (Zone IV) and maternal vasculature 
(Zone V). Zones designations mark areas in which CTB have distinct patterns of adhesion receptor expression 
as described in the Discussion section. 
Legend: AV - anchoring villus; FV - floating villus 
In the human placenta proliferating CTB stem cells are attached to an extensive 
basement membrane that surrounds the stromal core of two types of chorionic villi (Fig. 5.). 
In floating villi, CTBs differentiate by fusion to form an overlying layer of multinucleated 
STB. These cells are in immediate contact with maternal arterial blood that bathes the 
floating villi and their primary function is to perform nutrient, waste and gas exchange 
between the maternal and fetal circulations. In anchoring villi, beginning with the third 
post-ovulatory week, a subset of CTBs at the distal tips of the villi proliferate and 
differentiate by leaving their basement membrane to form multilayered cell columns 
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consisting of highly migratory, non-polarized, invasive CTBs, covered by a thin layer of 
syncytium. The cell columns expand distally, and populate the decidualized endometrium and 
the first third of the myometrium, thereby anchoring the villous tip to the uterine 
wall [26, 41], The penetrating cells spread over the maternal decidual cells, forming the 
cytotrophoblastic shell. Some of these deeply invasive cells penetrate the inner walls of the 
maternal spiral arteries up to their myometrial segments, and by replacing the endothelial 
lining and the smooth muscle cells, transform them in maximally dilated inert tubes. This 
process is termed endovascular invasion [3, 14, 24, 55, 72, 123], This unusual invasive 
behaviour has two important roles: (1) CTB invasion physically anchors the placenta to the 
uterus, and (2) by replacing the endothelial lining of the spiral arteries invasive extravillous 
CTBs create the large-diameter, low-resistance vessels that carry blood to the floating villi at 
the maternal-fetal interface. 
Extravillous trophoblast includes multiple cell populations: 
1. the cytotrophoblastic shell 
2. the residual trophoblastic elements within the chorion laeve 
3. the endovascular trophoblast 
4. the interstitial mononuclear and multinucleated trophoblast cells, which have invaded 
the decidual stroma (decidual trophoblast) and the inner third of the myometrium 
(interstitial trophoblast) [3, 96] 
5. large, multinucleated trophoblast cells in the extravillous locations (placental bed) 
termed placental bed giant cells [60, 96]; they are presumably non-invasive and 
remain essentially non-productive with respect to hormones (hCG, hPL) [96], 
The controlled invasion of the extravillous trophoblast into the endometrium is 
essential both for embryo implantation and haemochorial placentation and resembles the 
invasion of malignant tumor cells [17, 59, 80, 85, 92], However, unlike tumor invasion, 
trophoblast invasion is precisely developmentally regulated [59, 85], is confined spatially to 
specific areas in the uterus (endometrium and inner third of the myometrium), and temporally 
to early pregnancy (first trimester and early second trimester of gestation) [3, 54], However, 
the mechanisms regulating CTB proliferation and commitment to one or another 
differentiated trophoblast lineage, thus having a profound impact on the invasive-degradative 
behaviour of trophoblasts, is still a mystery. The elucidation of these mechanisms is subject 
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of numerous studies because disregulation of these processes can seriously affect the 
pregnancy outcome. Disorders such as preeclampsia [163] and approximately half the cases 
of intrauterine growth retardation [57] are associated with abnormally shallow CTB invasion. 
In contrast, an overly extensive invasion can result in both benign and malignant trophoblast 
tumors [13]. 
The hypothesis that cytokines may play a pivotal role in regulating human placental 
development and implantation has been much discussed in recent years [36, 70, 127]. Indeed 
the human placenta is an important site of both production and action of various cytokines 
and growth factors. Although numerous work has been published on the biological role of 
cytokines in the regulation of critical reproductive events like trophoblast proliferation, 
differentiation and function, the complex autocrine, paracrine and juxtacrine regulatory 
mechanisms involving these molecules are still far from being completely understood. Whilst 
the concept of cytokines influencing implantation and placentation is attractive, it has proved 
difficult to elucidate the mechanisms involved because it is not clear which cell type will 
respond to which cytokine. Therefore, a necessary initial step in the investigation of cytokine 
function is to define those cell populations which express relevant cytokine receptors as this 
would identify the potential responsive targets. 
Among the various cytokines and growth factors the recently described pleiotropic 
cytokine IL-10 has been proposed to be a factor that might protect the semiallogeneic fetus 
from maternal allorecognition and rejection by driving the maternal (both local and systemic) 
immune reaction toward a Th2-type immune response [30, 94], 
IL-10 was described initially as a "Cytokine Synthesis Inhibitory Factor" that shifts 
the body's immune reaction away from an inflammatory response (reviewed in 52; 66, 111, 
113). Although its serum levels were found to be stable throughout the menstrual cycle, once 
the pregnancy is established the circulating levels of IL-10 rise significantly [102], IL-10 
inhibits proinflammatory cytokine production including IL-ip, IL-6, IL-8, TNF-a and IFN-y 
[146, 155] therefore prevents the development of Thl-type immune reactions deleterious for 
both the establishment and maintenance of pregnancy [125, 156], Several studies have 
demonstrated that IL-10 can prevent naturally occurring fetal wastage in a murine model of 
immunologically mediated spontaneous early pregnancy loss [34], Earlier studies [142, 143, 
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144] stressed the role of IL-10 as a possible mediator of the immunological 
pregnancy-protective effect of progesterone. 
In human pregnancies, the protective role of IL-10 has been demonstrated by several 
findings concerning the disregulation of IL-10 production in some reproductive pathologies, 
including recurrent spontaneous abortion [64, 101], intrauterine growth restriction [63] and 
intrauterine infection-associated preterm labor [61]. Roth et al. were the first to describe that 
highly purified human CTBs secrete physiological amounts of IL-10 in vitro, independently 
of gestational age [130]. Furthermore, trophoblast-derived IL-10 was able to suppress IFN-y 
production of alloreactive lymphocytes in a mixed lymphocyte reaction, indicating that IL-10 
may contribute to the placental immune protection of the semiallogeneic fetus in a paracrine 
manner. Recently, these authors [129] have shown that CTB cells express IL-10R mRNA in 
vitro suggesting that, as well as its role as a regulator of materno-fetal relationship, this 
cytokine might also possess autocrin regulatory properties. 
Another epithelial cell which just as placental CTB stem cells undergoes a continuous 
process of proliferation and differentiation is the epidermal keratinocyte. Epidermis is subject 
to a life-long self renewing process during which quiescent stem cells laying on an extensive 
basement membrane are triggered to produce transiently amplifying cells, which then give 
rise to early stages of differentiation followed by terminal differentiation and death. 
Cytokines are likely candidates for regulating these processes and their role is even more 
evident in pathological conditions associated with a disregulation of keratinocyte 
proliferation and/or differentiation. 
Psoriasis is a common cutaneous disorder characterized by inflammation and 
abnormal epidermal proliferation with a prevalence of 2-3% in the general population [37], 
Several observations indicate that T cells and cytokines [22, 84, 117, 131, 151, 152, 158] are 
of major importance in the pathogenesis of this chronic skin disease. These observations are 
supported by the beneficial effects of systemic administration of immunosuppressive drugs 
like cyclosporin A [145], FK506 [68], and fumaric acid esters [2, 6, 42], known to act on T 
cells and to influence the cytokine pattern. 
According to the predominant expression of IL-2 and IFN-y and the lack of IL-4 in 
skin lesions, psoriasis is believed to be characterized by a type 1 cytokine pattern [128, 131, 
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151]. Moreover, the involvement of other proinflammatory cytokines like IL-1, IL-6, IL-8, 
and TNF-a has been demonstrated [50, 89,119]. 
In contrast to proinflammatory cytokines, there is only limited knowledge regarding 
the role of anti-inflammatory cytokines in psoriasis. Remarkably, there is rising evidence that 
a relative IL-1 receptor antagonist deficiency could be of major importance [83]. IL-10, 
another anti-inflammatory cytokine, is a potent inductor of IL-1 receptor antagonist [69], 
suggesting low or absent IL-10 expression in psoriasis. However, conflicting data have been 
published. Whereas IL-10 mRNA was detected rarely or not at all by some authors [131, 
151], overexpression has been reported by others [89, 120], Recent publications showed that 
subcutaneous administration of IL-10 has clinical efficiency in psoriasis [7], The presence 
and functionality of the IL-1 OR in human keratinocytes as well as its decreased expression in 
psoriatic epidermis has already been established [105], The possibility of raising IL-1 OR 
transcript levels by the treatment of epidermal cells with antipsoriatic compounds such as 
vitamin D3, calcipotriol [105] and steroids [104] has also been described. Therefore, the loss 
of negative regulatory elements such as the cell cycle control gene p53 [106] and the IL-1 OR 
in the pathogenesis of psoriasis might have at least the same importance as the excessive 
synthesis of proinflammatory and mitogenic signals, such as IL-8/IL-8R. 
On the basis of these data, the general aim of the present thesis was to expand our 
knowledge about the expression, functionality and possible pharmacological modulation of 
IL-lORs in two epithelia: trophoblast cells and epidermal keratinocytes. 
2 SPECIFIC AIMS 
2.1. The first aim of this thesis was the establishment of a reproducible method suitable for 
the simultaneous isolation of villous and extravillous CTB cells from first trimester human 
placenta. 
2.2. The purpose of further work was to investigate the expression of IL-1 OR at the protein 
level by CTB cells in vitro and to elucidate the placental localization of IL-1 OR expression in 
vivo, to define the subset of placental CTBs constituting the predominant target for the 
autocrine regulatory influence exerted by IL-10 during the first trimester of pregnancy. 
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2.3. The functional characterization of the IL-10R expressed by human first trimester 
CTBs with special emphasis on the possible role played by IL-10 in placental growth control 
through the regulation of CTB cell proliferation. 
2.4. The HaCaT cell line is widely used in experiments examining keratinocyte 
physiology and studying keratinocyte proliferation and differentiation. Since normal human 
keratinocytes express cell-surface IL-10Rs we sought to investigate the IL-10R expression by 
HaCaT keratinocytes at the protein level, as the presence of cell-surface IL-10Rs on these 
cells would open the possibility to use HaCaT cells as a model for studying the effects of 
IL-10 on keratinocyte physiology. 
2.5. As IL-10 is able to suppress the proliferation of normal human keratinocytes and in 
psoriasis a relative deficiency of IL-10 and a decreased expression of its receptor can be 
demonstrated, we set out to examine the possible effect of the potent antipsoriatic compound 
dithranol on the expression of IL-10Rs in human HaCaT keratinocytes. 
3 MATERIALS AND METHODS 
3.1 Isolation of first trimester human CTB cells 
CTB cells were isolated from first trimester placenta as described by Bischof et 
al. [18], Trophoblastic tissue was obtained from legal terminations of pregnancies performed 
in accordance with the Hungarian Abortion Law between 6-12 weeks of gestation. Villous 
tissue was dissected manually, rinsed and minced in HBSS (pH=7.4) containing 200 U/ml 
penicillin and 200 pg/ml streptomycin (both from Sigma, Budapest, Hungary). The minced 
tissue was then incubated at 37 °C four times for 20 minutes in HBSS containing 0.25% 
trypsin (Sigma, Budapest, Hungary), 50 U/ml DNase I (Sigma), 4.2 mM magnesium sulfate 
(Sigma), 25 mM HEPES (Sigma) and antibiotics (200 U/ml penicillin and 200 pg/ml 
streptomycin). The supernatant containing the dissociated mixed placental cells was 
collected, and the trypsin activity was neutralized by addition of 10% FCS (Gibco, Life 
Technologies, Vienna, Austria). The neutralized supernatant was centrifuged at 800 x g for 
10 minutes and the resulting cell pellet was resuspended in DMEM containing 25 mM 
HEPES, 200 U/ml penicillin, and 200 pg/ml streptomycin. The cell suspension obtained was 
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placed immediately into an incubator and was maintained at 37 °C until the end of the entire 
dissociation procedure. Concomitantly, the remaining villous tissue was subjected to another 
20 min trypsinization step. At the end of the dissociation procedure the remaining villous 
fragments were discarded. The four fractions of cell suspensions were pooled, filtered over a 
100 pm nylon mesh to remove remaining villous fragments, centrifuged at 800 * g for 10 
minutes, and resuspended in 2-3 ml of the same medium without FCS. This cell suspension 
was layered over a 5% to 70% preformed discontinuous Percoll gradient, according to the 
method of Kliman el al. [82]. The fraction containing the CTB cells (densities 
1.048-1.062 g/ml) was washed and resuspended in DMEM. These Percoll-enriched cells were 
immunopurified immediately and cultured, were stored in liquid nitrogen until 
immunopurified or were further used for flow cytometric analyses and/or 
immunohistochemical or immunofluorescent studies. The viability estimated by Trypan-blue 
exclusion was consistently >95%. 
3.2 Storage of cells in liquid nitrogen 
The Percoll-purified cells were suspended in cold FCS containing 10% DMSO 
(Sigma) to give 5-10 * 106 cells/ml. One ml aliquots of this cell suspension in 1.8 ml 
cryogenic vials (Corning Inc., N.Y., USA) were placed in insulated cardboard containers and 
kept at -70 °C overnight. Next day the tubes were rapidly transferred to liquid nitrogen for 
long term storage. When required, a tube was removed from the liquid nitrogen and thawed 
in a water bath at 37 °C. The thawed cells were diluted 1/10 in DMEM containing 20% FCS 
and centrifuged at 400 * g for 5 minutes. The cell pellet was resuspended in fresh culture 
medium to the required cell density. 
3.3 Immunopurification of CTB cells 
Cells (either freshly isolated or thawed after storage in liquid nitrogen) suspended in 
ice-cold DMEM (15-17 x io6 cells in 2 ml) were incubated for 30 minutes at 4 °C with 
100 pi of a monoclonal antibody to leukocyte common antigen (LCA, CD45, Dako A/S, 
Glostrup, Denmark) with occasional gentle shaking. In some experiments designed to obtain 
pure villous CTBs, the monoclonal anti-CD45 antibody was replaced with 50 pi of a 
monoclonal anti-HLA-ABC (clone W6/32) and 50 pi of monoclonal anti-HLA-DP, DQ, DR 
(clone CR3/43; both from Dako A/S). All the primary antibodies were raised in mice and 
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were added undiluted to the cell suspension. After incubation, the cells were washed with 
PBS (pH 7.4) containing 0.1% BSA (radioimmunoassay grade, Sigma). Prior to separation, 
100 pi of magnetic particles coated with a goat anti-mouse antibody (Dynabeads M-280, 
Dynal, Oslo, Norway) were washed twice with 5 ml PBS containing 0,1% BSA and stored at 
4 °C until used. The cell suspension was then incubated with the prewashed magnetic 
particles at 4 °C for 30 minutes with occasional gentle shaking. At the end of the incubation 
the tube was clamped to a magnetic concentrator (Dynal Laboratories, Oslo, Norway) for 5 
minutes. The supernatant containing the immunopurified CTB cells was removed from the 
tube and centrifuged at 800xg for 10 minutes at room temperature. The pelleted cells were 
resuspended in culture medium and plated as required (see bellow). 
3.4 Cell culture 
Purified CTBs were cultured in 24 well culture plates (Costar, Cambridge, MA., 
USA) under a 5% carbon dioxide and 95% air atmosphere in an incubator at 37 °C. The 
plating density was 0.5 * 106 viable cells/ml. When CTB differentiation was to be avoided 
the cells were cultured under serum-free conditions in DMEM containing 25 mM HEPES, 
200 U/ml penicillin, and 200 pg/ml streptomycin. In some experiments set out to study CTB 
differentiation, highly purified cells were cultured in 20% (v/v) FCS-containing DMEM or in 
KGM (Gibco) supplemented with 17% (v/v) FCS and antibiotics. Every other day the culture 
supernatant was gently aspirated and replaced with fresh media. After centrifugation at 800*g 
for 10 minutes in order to remove occasionally detached cells and any insoluble material, the 
culture supernatants were aliquoted and stored at -70 °C until assayed for hCG content or 
analysed for the presence of gelatin degrading proteases by zymography. For 
immunocytochemical characterization of cultured CTBs, the cells were plated on 13 mm cell 
culture treated plastic coverslips (Menzel-Glaser). 
The spontaneously transformed human epidermal cell line HaCaT (kindly provided by 
Dr. N. E. Fusenig, Heidelberg, Germany) was cultured in DMEM containing 10% FCS. 
3.5 Hormone assays 
Total human chorionic gonadotropin (hCG + (3 hCG) was measured in the culture 
supernatant with a microparticle enzyme immunoassay kit kindly provided by the WHO 
(WHO Matched Assay Reagents for the Immunoassay of Hormones). The sensitivity of the 
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assay was 2 mlU/ml. The average intra- and interassay coefficient of variation was 3,6 % and 
7,2 %, respectively. 
3.6 Zymography 
The presence of gelatinolytic metalloproteinases in the supernatants of CTBs cultured 
for 24 hours was assessed by zymography with a modification of the technique described by 
Fisher etal. [54]. Briefly, 10% polyacrylamide gel in 0,1% SDS containing 1 mg/ml gelatin 
(all from Sigma, Budapest, Hungary) were cast at a final dimension of 80 x 85 x 1 mm. After 
the polymerization of the 10% running gel, a 2% polyacrylamide stacking gel was cast above 
the previous one. Thirty microliters of molecular weight standards (Pharmacia, Uppsala, 
Sweden) and samples were incubated 5 minutes at room temperature with 5 pi sample buffer 
containing 17.4% SDS, 7% sucrose, and phenol red in distilled water. Twenty five microliters 
of the incubate were applied to the gel. After electrophoresis, gels were subjected to six 
5-minute washes in 2.5% Triton X-100 in distilled water to allow proteins to renature, 
followed by three 5-minute washes in PBS containing 0.9 mmol/1 calcium chloride and 
magnesium chloride and were incubated overnight at 37 °C. Next morning the gels were 
stained with Coomassie Brilliant Blue G250 (0.1% in 25% methanol and 10% acetic acid in 
distilled water) and destained in 5% methanol and 7.5% acetic acid in distilled water. 
3.7 Analysis of JL-10R expression on first trimester CTBs 
The expression of IL-10R was determined for Percoll gradient purified CTBs using an 
IL-10 Fluorokine Kit (R&D Systems Gmbh, Wiesbaden, Germany) according to the 
manufacturer's protocol. Briefly, the freshly isolated cells were incubated overnight at 37 °C 
in serum-free culture medium, under conditions that did not allow them to attach (i.e. in 
solution, on rocking platform or on agarose coated culture dish). Next day the cells were 
washed (in order to remove any residual growth factors present in the culture medium), and 
separated into two groups to which the biotin-conjugated IL-10 or the biotin-labeled control 
protein (soybean trypsin inhibitor) were added. After 1 hour incubation at room temperature 
avidin-FITC was added, followed by an additional 1 hour incubation, washing and 
resuspension in a specific buffer designed by the manufacturer to stabilize specific staining 
and minimize background. Analysis was conducted on a FACStarPLUS (Becton Dickinson, 
Erembodegem-Aalst, Belgium) flow cytometer with a 488 nm argon-ion laser excitation 
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device. The cells were first analyzed for forward and side scatter to gate out debris, and to 
select the CTBs based on their relatively large size and primitive cytoplasmic structure. 
3.8 Immunofluorescent staining of purified CTBs 
Immunopurified CTB cells (2,5-5* 104 cells/100 pi PBS) were centrifuged at 700 * g 
onto glass slides with a cytospin centrifuge. After drying, the obtained cytospin smears were 
fixed in acetone at -20 °C for 15 minutes. For the characterisation of CTBs cultured 24 hours 
on 13 mm plastic coverslips, cells were fixed 15 minutes in a 1:1 mixture of ethanol and 
acetone at -20 °C. Until stained, both the cytospin smears and the coverslips with cultured 
CTBs were stored at -20 °C. Before staining the cells were rehydrated 15 minutes in PBS 
(pH 7.4) at room temperature. In the mean time primary antibodies were diluted in PBS 
containing 1% FBS. The coverslips and cytospin smears were incubated with 20 pi of the 
primary antibody in a humid chamber at 37 °C for 1 hour. The primary antibodies (mouse 
anti-human cytokeratin, clone MNF116 diluted 1/10 and rabbit anti-human 0-hCG undiluted, 
used for the detection of trophoblast cells and mouse anti-human vimentin, diluted 1/20, 
which labelles stromal cells) were from Dako A/S. After 60 minutes the cells were washed 
three times in PBS, for 10 minutes each, followed by a 45 minute incubation with the 
FITC-conjugated second antibody (goat anti-mouse Ig, 1/100, Sigma; sheep anti-rabbit Ig, 
1/16, Miles-Yeda Ltd.) at 37 °C. After two 10 minute washes in PBS, the cells were stained 
with Evans Blue (diluted 1/10 000 in PBS) (Sigma) in order to reduce the intensity of 
non-specific fluorescence. After mounting with an aqeous mounting medium, the cell 
preparations were examined under a Leitz UV microscope and the results were expressed as 
the percentage of positive cells per 300 total cells counted. 
3.9 Immunohistochemistry 
The IL-10R monoclonal antibody, specific for the extracellular, ligand binding 
domain of the cell-surface IL-1 OR, was obtained from R&D Systems. The mouse monoclonal 
antibodies to as (CD 49e, clone SAM1) and ct6 (CD 49f, clone 4F10) integrin subunits were 
obtained from Immunotech (Coulter, Marseille Cedex, France) and Serotec (Kidlington, 
Oxford, UK), respectively. The anticytokeratin antibody (clone MNF116) used to identify 
CTB cells within chorionic villi was obtained from Dako A/S. A monoclonal antibody 
against the proliferation marker Ki-67 (clone Ki-S5) was from Boehringer Mannheim 
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(Vienna, Austria). Negative control slides were stained with mouse IgG class-matched 
irrelevant antibodies, obtained from Dako A/S. All antibodies and negative control reagents 
were diluted to a working concentration of 1 pg/ml in TBS, containing 0.1% Triton X-100 
and 0.5% BSA (both from Sigma). 
Samples of first trimester placental tissue (6-12 weeks of gestation) were taken from 
routine vaginal terminations of pregnancies. For the investigation of the role played by IL-10 
in the regulation of CTB proliferation, chorionic villi were placed on filter papers within 24 
well plates (Costar) and cultured under serum-free conditions in 2 ml of 
penicillin-streptomycin containing DMEM. The placental explants were cultured in medium 
alone, in the presence of increasing concentrations of IL-10 (0.1-10 ng/ml) (R&D Systems) 
and some cultures were treated concomitantly with 10 ng/ml IL-10 and 10 pg/ml of an 
IL-10R specific function blocking antibody (R&D Systems). After 24 hours the CTB 
proliferation was assessed by immunohistochemistry using a monoclonal antibody directed 
against the proliferation marker Ki-67. Both freshly obtained and cultured placental tissue 
fragments were immediately frozen in Cryomatrix (Shandon, Cheshire, UK). Six pm frozen 
sections were thawed, air dried, fixed in acetone for 10 minutes at 4 °C, and rehydrated in 
TBS containing 0.1% Triton X-100. Slides were then incubated for 30 minutes at 4 °C with 
human IgG (0.5 mg/ml, heat aggregated at 65 °C for 20 minutes) (Jackson ImmunoResearch 
Laboratories Inc., West Baltimore Pike, USA), in order to block cell-surface Fc receptors. 
Excess liquid was blotted without washing, and the sections stained for 1L-10R and Ki-67 
were incubated overnight at 4 °C. Slides stained for cytokeratin, ot6 and as integrin subunits 
were incubated for 1 hour at room temperature. The antigen-antibody reaction was revealed 
by using a StreptABComplex Duet (mouse and rabbit) Reagent Set (Dako A/S). Briefly, the 
slides were incubated for 1 hour at room temperature with the biotin-labeled second antibody 
(goat anti-mouse/rabbit Ig). After washing, avidin-HRP was added and the incubation was 
performed in similar conditions as described for the second antibody. The peroxidase was 
developed with AEC as substrate (Sigma). Finally, the sections were washed in tap water, 
counterstained with hematoxylin, rewashed and mounted in DAKO Glycergel® aqeous 
mounting medium. 
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3.10 Western blot analysis 
Total protein extracts from cultured chorionic villi were prepared in a lysis buffer of 
1.5% SDS, 62.5 mM Tris-HCL pH 6.8, 5mM EDTA, 5% 2-mercaptoethanol, 1 pg/ml 
antipain, 1 pg/ml chymostatin, and 1 pg/ml leupeptin (all from Sigma). Lysates were 
precleared by centrifiigation at 12 000 * g for 15 minutes and supernatants were aliquoted 
and stored at -20°C. The constituent proteins of the chorionic villi extracts were separated by 
SDS/PAGE on a 6% separating gel and then transferred to nitrocellulose membrane (Bio-Rad 
Laboratories). In order to verify the equivalent loadings of proteins in the wells, the gel and 
the nitrocellulose was stained by Coomassie Brillant Blue and Ponceau S, respectively 
(Sigma). Membranes were blocked by incubation in TBS (150 mM sodium chloride, 25 mM 
Tris-HCl, pH 7.4), containing 0.05% Tween 20 (Sigma) and 2% nonfat dry milk (Fluka 
Chemie AG, Neu-Buchs, Switzerland), for 2 hours at room temperature and subsequently 
incubated overnight at 4 °C with the monoclonal antibody specific for the S-phase marker 
Ki-67, diluted to a working concentration of 1 pg/ml in blocking buffer. AP-conjugated 
rabbit anti-goat IgG (Sigma) was used as secondary antibody at 1:2500 dilution in the 
blocking buffer. After incubation with the second antibody for 2 hours at room temperature, 
blots were developed by using BCIP/NBT as substrate (Sigma). 
3.11 Analysis of IL-10R expression on HaCaT keratinocytes 
The subconfluent HaCaT keratinocytes were washed with PBS under sterile 
conditions and were incubated for 30 minutes at 37 °C in a humid 5% carbon dioxide 
atmosphere incubator with increasing concentrations of dithranol (0.1-0.5 pg/ml) (Hermal 
Chemie, Reinbek, Germany) in DMEM containing 0.5% FCS. Dithranol was always freshly 
dissolved in acetone and used immediately. Control cells were treated with the solvent 
(acetone) only or left untreated. 
Dithranol treated cells were then washed with PBS and were incubated in DMEM 
containing 10% FCS for 2 and 4 hours at 37 °C before immunohistochemical staining for 
IL-10R. The staining protocol for the detection of IL-10R was identical with that used for the 
characterization of IL-10R expression in first trimester chorionic villi. 
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4 RESULTS 
4.1 Isolation and characterization of first trimester CTB cells 
Figure 6. Frozen section of placental villi 
stained with monoclonal antibody to 
cytokeratin. Cytokeratin is strongly 
expressed by both the cytotrophoblast 
monolayer (ctb) and the overlying 
syncytiotrophoblast (stb). 
(vs, villous stroma; ivs, intervillous space). 
Bar = 50 pm 
In order to isolate first trimester CTBs an enzymatic dissociation method followed by 
density gradient centrifugation and subsequent immunomagnetic purification was applied. 
Cell purification was monitored by staining the cells with an anticytokeratin antibody specific 
for cytokeratins 5, 6, 8, 17 and probably also 19 (Clone MNF116). The antibody has been 
selected on the basis of our immunohistochemical data which showed that within first 
trimester placental villi it stains only trophoblasts (Fig. 6.), a finding which was already 
reported by others [1]. For the characterization of freshly isolated CTB cells the experiments 
were repeated at least three times with different CTB preparations obtained from pooled 
placental tissues. The density gradient centrifugation yielded a cell suspension consisting of 
78-86% CTBs as judged by cytokeratin positivity of cytospin smears obtained from freshly 
isolated cells. Approximately one third (32-45%) of the Percoll-enriched cell suspension 
stained positive with the HLA-ABC specific monoclonal antibody, indicating either an 
extravillous origin of trophoblastic cells or the presence of lymphomyeloid contaminants. 
Since placentas are usually obtained from first trimester terminations of pregnancy, the most 
likely contaminants of CTB cell preparations are lymphomyeloid cells. One of the most 
reliable markers used to detect lymphomyeloid cells is the leukocyte common antigen CD45. 
After Percoll gradient centrifugation the proportion of CD45 positive cells in our CTB 
enriched cell suspensions was 16-32% (data not shown). 
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Percoll-isolated cells were further purified using an immunomagnetic procedure by 
which the CD45-positive cells were eliminated. In order to obtain pure villous CTB cells, in 
some experiments the immunopurification was performed using a 1:1 mixture of a 
monoclonal mouse antibody to the HLA-ABC epitope of class I MHC antigens and an 
antibody specific for the HLA-DP, DQ, and DR epitopes of the class II MHC loci. This step 
took advantage of the fact that villous trophoblast is one of the few tissues to lack MHC 
antigens on its surface [28, 51, 141], Highly purified CTBs, irrespective of the antibodies 
used during immunopurification, were 95-99% cytokeratin-positive, the HLA-ABC positive 
cells fell bellow 3% of total cells counted and the CD45-positive lymphomyeloid cells 
became undetectable, as shown both by immunocytochemistry and immunofluorescent 
studies of cytospin smears. The low level contamination by vimentin-expressing fetal stromal 
cells was not affected by the immunopurification and accounted for < 6% of total cells 
counted (data not shown). 
After the elimination of CD45-positive contaminating cells the remaining CTB cell 
population consisted of 18-22% as-integrin expressing and 25-38% ot6-integrin expressing 
CTBs, showing that the isolated cell population consisted of villous and extravillous cells 
(data not shown). 
As shown by Trypan blue exclusion, >95% of the Percoll-isolated cells retained 
viability, which was not affected neither by immunopurification, nor by storage under liquid 
nitrogen. 
4.2 Culture of first trimester CTB cells 
Similar to the characterization of isolated CTBs, cell culture experiments were repeated 
at least three times with different cell preparations. In the presence of 20% (v/v) FCS, >80% 
of mononuclear CTBs adhered to the culture plastic within 6 hours of culture. After 12-24 
hours, the cells flattened out and formed colonies of 5-6 aggregated cells, which were 
cytokeratin positive as shown by immunofluorescent staining (Fig. 7A. and 7B.). Over 6 days 
in culture, the number and the size of the morula-like cellular aggregates increased 
continuously, and on the 6th day single cells represented <15% of the total cultured CTBs. 
Contaminant spindle shaped fibroblasts were < 3% of total cells. Beginning with the 4th day 
of culture the cell boundaries became hardly distinguishable under phase contrast microscopy 
(Fig. 8B.) and during subsequent culturing syncytium-like structures appeared. 
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Figure 7. Immunofluorescent staining of highly purified CTB cells. (A) Cytospin smear of freshly isolated 
CTBs stained for cytokeratin. (B) Cytokeratin staining of CTBs cultured 24 h in 20% (v/v) FCS containing 
DMEM on coverslips. (C) Cytokeratin staining of CTBs cultured 6 days in KGM containing 17% (v/v) FCS, on 
coverslips. (D) Immunofluorescent staining of (3hCG. CTB cells were cultured 6 days in KGM supplemented 
with 17% (v/v) FCS on coverslips. (E) Multinucleated cells resembling syncytiotrophoblasts. After 5 days of 
culturing in KGM supplemented with 17% (v/v) FCS on coverslips, cells were stained with Evans Blue. 
Figure 8. Phase contrast micrographs of first trimester human cytotrophoblast cells cultured for 4 days in 
serum-free Dulbecco's Modified Eagle Medium (A) or in presence of 20% (v/v) fetal calf serum (B). 
Bar = 50 pm 
In the absence of serum < 80% of CTBs adhered after 12 hours of culture and the 
majority of cells remained round-shaped. After 24 hours some mononuclear CTBs formed 
small colonies of aggregated cells. Over time the number and the size of the aggregates 
remained essentially unchanged and the cell boundaries were well distinguishable with phase 
contrast microscopy (Fig. 8A.). The percentage of single cells remained around 30-40%. 
When HLA-ABC and HLA-DP, DQ, DR depleted pure villous CTBs were cultured in 
KGM containing 17% FCS, extensive cell aggregation was noticed. After 5 days of culturing 
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multinucleated cells resembling STBs formed (Fig. 7E.). The trophoblastic origin of these 
cells was confirmed by cytokeratin and P hCG staining (Fig. 7C. and 7D., respectively). 
The secretion of the pregnancy hormone hCG by the CTB cell population depleted of 
CD45-positive lymphomyeloid cells increased abruptly when the cells were cultured in 
DMEM containing 20% FCS (Fig. 9.). On day 4 the concentration of total hCG in the culture 
supernatant was twice as much as in the 2nd day supernatant and by the 6th day the 
concentration of the hormone was six times more than that measured on the 2nd day of 
culture. In contrast, the amount of hCG secreted by CTB cells cultured under serum-free 
conditions increased slowly: twice the concentration of the hormone in the 2nd day culture 
supernatant was recorded only by the 6th day of culture. This pattern of hCG secretion 
correlated well with the rate of syncytium formation and hCG positivity. In some experiments 
the 24 hours hormone production of the cultured CTB cells was also measured. Our results 
indicate that during 24 hours the hCG production of the cells was as small as 
143.12 ± 104.56 IU/L (average ± SD, N=4 cell preparations from 9 different placentas) and 
differed significantly from one cell preparation to another. During the first 24 hours of culture 
the hCG secretion by CTB cells was not changed by the addition of 20% FCS to the culture 
medium. Immunopurification did not change the secretion of hCG by CTB cells (data not 
shown). 
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Figure 9. Secretion of hCG by first trimester cytotrophoblast cells cultured in Dulbecco's Modified Eagle 
Medium under serum-free conditions or in the presence of 20% (v/v) fetal calf serum. Results are means (N=3). 
and error bars represent standard deviations. 
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Metalloproteinase secretion is an important characteristic of CTB cells, thus for a 
more complete characterization of our CTB preparations we set out to examine the array of 
cell-secreted metalloproteinases using substrate gels copolymerized with gelatin. For this 
purpose isolated cells depleted of CD45 expressing contaminants, which might also secrete 
gelatin-degrading proteases, were cultured for 24 hours in serum-free DMEM. Analysis of 
gelatin-degrading activity in CTB-conditioned media revealed a single digestion band in the 
90 kD region (Fig. 10.). These findings are in accordance with the previously reported data 
by Fisher et al. [54] showing that early placental CTBs secrete only the 92 kD matrix 
metalloproteinase (MMP-9) into the culture medium. 
kD 
Figure 10. Zymographic analysis of gelatin-degrading activity in CTB-conditioned media from N=5 different 
CTB preparations. CD45-depleted CTBs were cultured for 24 hours in serum-free DMEM as described in 
"Materials and Methods". 
Taken together, the described morphological data, as well as differentiation studies, 
hCG and metalloproteinase secretion patterns demonstrate that the isolated cells are CTBs. 
4.3 Flow cytometric analysis of IL-10 receptor expression in vitro on first trimester 
CTB cells 
Binding experiments performed on Percoll-purified first trimester CTBs using biotinylated 
IL-10 and avidin-FITC have demonstrated, that above 75-80% of the cells were able to bind 
the labelled cytokine, as indicated by the FACS hystogram (Fig. l ib.). Cells were also 
•r 
stained with a monoclonal antibody against cytokeratins (clone MNF116). Of the cells, 75-
80% showed positive staining (Fig. 1 Id.) relative to the isotype control (Fig. 11c.), indicating 
that the cytokeratin positive population (i.e. CTBs) and IL-10 receptor expressing cells might 
be the same. Unspecific binding was ruled out by the negative control experiments, where the 
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biotinylated IL-10 was substituted by biotin-labelled soybean trypsin inhibitor (Fig. 11a.). 
This protein is unable to bind specifically to any known cell-surface receptor, therefore the 
fluorescence of these cells is identical to that of the background. For the specific binding it 
was essential to maintain the cells in serum-free media overnight under conditions that did 
not allow them to attach (i.e. in solution, on rocking platform or on agarose coated culture 
dish). Freshly isolated cells, as well as cultured cells, treated with trypsin to remove them 
from the culture plates, did not bind labelled IL-10 at all (data not shown). This finding 
indicates that IL-lORs expressed by early human CTB cells are trypsin sensitive. 
Figure 11. Negative controls of cytotrophoblast cells stained with biotin-labeled soybean trypsin inhibitor (a) 
and non-immune mouse IgGi (c) were used to determine background staining. Representative experiment of 
cytotrophoblast cells analysed by flow cytometry for IL-10 receptors (b). Representative experiment of 
cytotrophoblast cells pcnneabilized overnight in 70% ethanol at -20 °C, and analysed by flow cytometry for 
cytokeratins (d). x axis = fluorescence intensity, y axis = relative number of cells, M = marker. 
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4.4 Immunohistochemical detection of IL-lORs in human first trimester placental 
tissues 
Reactivity to IL-10R specific monoclonal antibody was detected in all (N=12) first 
trimester preparations (Fig. 12. shows the result of a representative experiment). The most 
intense staining was observed in trophoblast cells forming the internal layer of villi 
(i.e. villous CTB), meanwhile the external STB layer was negative (Fig. 12A.). The CTB 
cells which expand from the tip of anchoring villi shortly after implantation and form CTB 
cell columns also reacted with the IL-10R specific monoclonal antibody (Fig. 12B.). The 
most intense reactivity was observed in the proximal cells of these columns, located nearest 
the villous stroma. In contrast, cells located more distally stained only weakly, if at all. In all 
experiments, reactivity to IL-10R specific antibody was localized to the cell membrane with 
no reactivity in the cytoplasm of the cells. Moreover, CTB cells resting on the villous 
basement membrane (villous CTBs and the first row of CTB cell columns) stained intensely 
along the apical and lateral microdomains of their cellular membranes. This staining pattern 
suggests that CTB cells express cell-surface IL-lORs in a polarized manner. Cells of the 
villous stroma were always negative, showing that in the first trimester of pregnancy these 
cells do not express IL-lORs. 
4.5 Expression of as and a* integrin subunits in human first trimester placentas 
In order to specify more precisely the subsets of IL-10R bearing CTB cells in vivo, in 
parallel we have studied the pattern of integrin expression in our first trimester placental 
tissue preparations. Villous CTB cells resting on villous basal lamina expressed 06 integrin 
subunit clustered along the basement membrane (Fig. 12E.). Proximal cells of CTB cell 
columns resting on the basement membrane of the villous tip have preserved this pattern of 
expression. In contrast, more distal but still closely packed CTBs of cell columns expressed 
06 integrin subunit in an unclustered way. Concomitantly, a gradual reduction of staining 
intensity towards the distal, deeply invasive cells was observed. Villous STBs and deeply 
invasive cells of CTB cell columns were always negative. 
When serial sections stained for as integrin subunit were examined and compared to 
those stained for 06 integrin, a reciprocal staining pattern was observed: as integrin 
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expression reached its maximum in distal cells and gradually decreased towards the proximal 
part of cell columns (Fig. 12F.). In villous CTB no staining for as integrin subunit was seen. 
Figure 12. (A) Frozen section of placental villi stained with monoclonal antibody (Mab) to IL-10 receptor. The 
IL-10 receptor is strongly expressed by villous cytotrophoblast (arrows) but the overlying villous 
syncytiotrophoblast (stb) is negative (vs, villous stroma; ivs, intervillous space). (B) Frozen section of placental 
villi stained with Mab to IL-10 receptor showing an anchoring villous. The IL-10 receptor is strongly expressed 
by cytotrophoblast cells anchored to the basement membrane covering the villous tip (arrowheads) and by 
villous cytotrophoblasts (arrows). Cytotrophoblast cell column emerging from the villous tip (cc) and 
syncytiotrophoblast (stb) stain much more weakly if at all. Cells in the villous stroma (vs) are negative. (C) 
Frozen section of placental villi stained with non-immune class matched mouse IgG showing that the villous 
cytotrophoblasts and syncytiotrophoblasts (arrows) are negative (vs, villous stroma; ivs, intervillous space). (D) 
Frozen section of placental villi stained with non-immune class matched mouse IgG showing a part of the 
invasive cytotrophoblast cell column (cc). (E) Frozen section of placental villi stained with Mab to the a 6 
integrin subunit. The a 6 integrin subunit is strongly expressed by villous cytotrophoblasts (arrows) but the 
villous syncytiotrophoblasts (stb) are negative. There is a reduction in staining intensity for a 6 in the distal part 
of the cytotrophoblast cell column (cc). (F) Frozen section of placental villi stained with Mab to the a 5 integrin 
subunit. Villous cytotrophoblast and syncytiotrophoblast cells do not stain (arrows). Expression of a 5 integrin 
increases from the proximal towards the distal part of the cytotrophoblast cell column (cc). (vs, villous stroma; 
ivs, intervillous space) Bar = 50 pm. 
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4.6 The functional characterization of the IL-10R: the role of IL-10 in placental 
growth control through the regulation of CTB proliferation 
Immunohistochemical analysis of placental explants from N=8 different placentas 
indicated that IL-10 reduces dramatically the number of the Ki-67 positive CTB nuclei within 
first trimester placental villi, whereas the proliferation of other cell types remained unaffected 
(Fig. 13.). We did not observe any difference in the Ki-67 staining pattern of chorionic villi 
treated with different concentrations of IL-10. 
In order to assess quantitative changes and dose-dependence which might not be 
revealed by immunohistochemical staining, in parallel we performed immunoblot analysis to 
clarify whether the proliferation inhibiting effect of IL-10 on villous CTB cells was 
dose-dependent. The western blot analysis, similar to the immunohistochemical results 
demonstrated that the expression of the Ki-67 antigen is markedly suppressed upon treatment 
with IL-10 (Fig. 14.). This effect proved to be maximal even at the lowest concentration of 
IL-10 and was reversible by the IL-10R specific function blocking antibody, showing that the 
observed biological changes were mediated through specific cell-surface IL-10Rs. 
Figure 13. Frozen section of first trimester chorionic villi cultured for 24 hours (A) in Dulbecco's Modified 
Eagle Medium alone or (B) in the same medium supplemented with 10 ng/ml IL-10 and subsequently stained 
with a monoclonal mouse antibody to the S-phase marker Ki-67. Nuclear staining is confined to villous 
cytotrophoblast cells (arrows) and cytotrophoblasts of cell columns emerging from the villous tip (cc). In IL-10 
treated chorionic villi the number of Ki-67 positive cytotrophoblast nuclei is markedly reduced, (vs, villous 
stroma; ivs, intervillous space) Bar= 100 pm. 
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Figure 14. Western immunoblot analysis of Ki-67 antigen expressed by first trimester chorionic villi cultured ex 
vivo for 24 hours in serum-free Dulbecco's Modified Eagle Medium. Lane 1, the position of the prestained 218 
kD molecular weight standard. Lane 2, chorionic villi cultured for 24 hours in medium alone; lane 3, 4 and 5, 
chorionic villi treated with 0.1, 1, and 10 ng/ml IL-10, respectively. Lane 6, chorionic villi treated concomitantly 
with 10 pg/ml of an IL-10 receptor specific function blocking antibody and 10 ng/ml IL-10. The monoclonal 
mouse anti-Ki-67 antibody recognized two bands of 345 kD and 395 kD, respectively identical with the Ki-67 
antigen (arrows). 
4.7 IL-10 receptor expression at the protein level in HaCaT cells 
Untreated cultured HaCaT cells were stained with a monoclonal antibody against 
human IL-10R. Relative to the isotype control the antibody clearly stained the cells. A clear 
membrane localisation was apparent and interestingly it seemed that cells localized at the 
edges of the colonies showed stronger expression. Beside the membrane staining there was 
some cytoplasmic staining as well (Fig. 15.). We have also performed immunocytochemistry 
on cultured HaCaT cells that were treated with dithranol. At all concentrations tested 
(0.1-0.5 pg/ml) the dithranol clearly had a cytostatic effect on the cells, that was apparent by 
the size of the cell colonies relative to the untreated control cultures. With the monoclonal 
antibody staining there was a slight indication for enhanced expression of IL-10R, 
predominantly on the cell membrane in the dithranol treated cultures, and this difference 
seemed to depend on the concentration (Fig. 16.). 
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Figure 15. Immunocytochemistry with a monoclonal Figure 16. Immunocytochemistry with a monoclonal 
antibody against human IL-10R on cultured HaCaT antibody against human IL-10R on cultured HaCaT 
cells. (A) HaCaT cells with clear membrane cells that were treated with dithranol. (A) 0,1 m g/ml 
localization of the human IL-10 receptor. (B) Isotype dithranol treated HaCaT cells. (B) 0,25 m g/ml 
control. dithranol treated HaCaT cells. 
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5 DISCUSSION 
High purity isolation of living CTB cells represents an important step toward 
understanding the process of human embryo implantation since nidation is considerably 
morphologically different in humans than in experimental or domestic animals [157], These 
morphologic variations presumably rely upon fundamental differences at the cellular and 
molecular levels [39], For ethical reasons, in vivo human experimentation to study the steps 
of implantation is not feasible. However, elucidation of the mechanisms of human 
implantation is gaining strong importance, given the recent advances in assisted reproductive 
technologies and the search for new methods of contraception. In addition, very little is 
known about factors controling trophoblast proliferation, differentiation, and invasion, which 
explains the increasing attention recently paid by the scientific community to the study of cell 
biological and molecular events which govern these processes both in vivo and in vitro. 
Without any question, for in vitro characterization at the cell and molecular level, highly 
purified trophoblast cells are needed. To fulfill these needs, several attempts to isolate human 
trophoblast cells have been reported. In essence, these methods include: 
• physical separation methods [82] 
• physical and/or immunomagnetic separation methods [47] 
• cell attachment procedures [99] 
• sequential enzymatic digestion and Percoll gradient centrifugation [54, 82] 
• selective culture conditions [97, 159] 
• sedimentation methods [48, 81, 82, 116, 139] 
• immunological or receptor-binding methods [18, 33, 38, 47, 98, 112, 133, 139, 
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149] 
• selective disaggregation conditions [9, 27] 
• immuno-flow cytometric cell sorting methods [21]. 
The difficulty in obtaining a preparation of pure trophoblast cells for culture can be 
appreciated by understanding the structure of the placenta. The outer surface of the chorionic 
villi is covered by the STB, underlying which is a single layer of CTB cells anchored to the 
villous basement membrane. A microvascular network connects this layer to the umbilical 
arteries and vein. The apical membrane of the STB is folded into numerous microvilli 
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forming a brush-border membrane. Disaggregation of this villous tissue results in a broken 
syncytial membrane, releasing not only CTB cells, but also other cell populations 
(macrophages, fibroblasts, giant cells, some adhering decidual cells, as well as endothelial 
cells) and DNA from syncytial nuclei. Separation of CTBs from this heterogeneous cell 
population has proven to be a challenge. 
The present protocol to enrich a reasonable number of highly purified CTB cells from 
human first trimester placentae depends on the initial crude mechanical dissection of the 
chorionic villi from adhering decidual tissue fragments and fetal membranes, gentle 
enzymatic treatment to separate the CTB and STB layers from the mesenchyme, enrichment 
of CTB cells by Percoll gradient sedimentation and immunomagnetic purification using 
monoclonal antibodies to CD45 to remove bone marrow-derived cells or to various epitopes 
of the MHC molecules (HLA-ABC, HLA-DP, DQ, DR) to obtain a pure villous CTB 
population. 
CD45 is a tyrosine phosphatase present on bone marrow-derived cells [35, 138], but 
absent on CTB cells [92]. Class I and class H MHC molecules are present only on 
contaminating cells but are absent on trophoblasts. HLA-ABC have been identified on 
invasive extravillous CTBs [19; for review see ref. 72], Therefore, the elimination of HLA-
ABC expressing cells by immunopurification yields a cell suspension consisting only of 
undifferentiated (i.e. villous) CTBs, whilst the CD45 depleted cells contain both villous and 
differentiating extravillous CTB populations [19], 
The specific type and number of CTB cells isolated by this method is further 
determined by the age of the placenta and the time of enzymatic digestion. 
Immunocytochemical studies of freshly isolated cells indicated that our 
Percoll-enriched CTBs still contain an appreciable and hardly controllable proportion of 
contaminating cells. The immunopurification step using either CD45 or HLA-ABC and 
HLA-DP, DQ, DR specific monoclonal antibodies decreased effectively the proportion of 
contaminating cells yielding a highly pure CTB population (92-98% CTBs). In addition, 
neither the immunopurification, nor the storage of cells in liquid nitrogen affected cell 
viability, which was always above 95%, as assessed by Trypan-blue exclusion. 
On the basis of morphological criteria and hCG production, the CD45 depleted cells 
underwent rapid differentiation when cultured in serum supplemented media. Similar to 
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previously reported data by Fisher et al. [54], the analysis of substrate gels indicated that 
these cells secreted a single gelatinolytic enzyme with a molecular weight of approximately 
90 kD, probably identical with MMP-9. All these data confirmed the trophoblastic origin of 
our cell preparations. 
In human placenta at least two major morphologically and functionally distinct CTB 
populations can be identified. Villous CTBs are polarized immotile cells anchored to the 
basement membrane of chorionic villi. They differentiate by fusion to form the overlying 
syncytium which is in direct contact with maternal blood, mediating nutrient and gas 
exchange for the developing fetus, and representing the major endocrine component of 
human placenta. Extravillous, invasive CTB cells rise from CTBs that rest on the basement 
membrane surrounding the tip of anchoring villi. These cells differentiate by leaving their 
basement membrane and form non-polarized cellular aggregates (i.e. CTB cell columns). 
They give rise to the invasive CTB population, which invades the endometrium, its arterial 
system, thus connects the developing fetus to the maternal circulation. No relevant 
differences were reported between basement membrane-anchored cells giving rise to the 
extravillous trophoblast and those underlying the villous syncytial trophoblast, therefore it is 
very likely that both kinds of cells represent a uniform cell population, which can equally 
differentiate in either of the two major pathways already mentioned [72], 
Previous immunohistochemical [4, 20, 41] and functional [29] studies have shown 
that CTB cells modulate their integrin repertoire during invasion of the endometrium. These 
authors have demonstrated that villous CTB cells, resting on a laminin rich basement 
membrane, express the integrin 0604 (a laminin receptor) in a clustered manner towards the 
basement membrane. When leaving their basement membrane at the tip of anchoring villi to 
form cell columns, they continue to express the integrin 0604, but in an unclustered way. 
CTBs located deeper in the placental bed have lost their capacity to express the integrin ct604, 
and instead express Os0i integrin, the major fibronectin receptor. Therefore, as trophoblast 
cells are gradually transformed from polarized villous epithelial layer into non-polarized 
extravillous population, a down-regulation of O604 integrin expression with a reciprocal 
up-regulation of as0i integrin occurs. Our immunohistological findings regarding the 
placental localization of (X6 and as subunit expressing CTB subpopulations fit these reports 
perfectly. This gradual switch from the basal lamina receptor oi604 to interstitial receptors 
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such as asPi, was regarded as a mechanism by which invasive CTB cells adapt to their 
successive environments [15, 16], These authors have shown, that this integrin switch is 
paralleled by significant changes in the invasive behaviour of CTBs [19]. If villous STB and 
deeply invasive extravillous CTB cells are considered terminally differentiated forms of the 
same ot6 integrin-positive CTB stem cell, the above mentioned integrin switch might equally 
be an expression of cellular differentiation. 
Another important conclusion which derives from these immunohistochemical results 
is that as and ct6 integrin subunit expression may be useful to further analyze the proportion 
of undifferentiated villous and differentiating extravillous cells in the isolated CTB 
population. Our immunocytochemical studies performed on cytospin smears obtained from 
CD45-depleted CTBs confirmed the presumption that these CTBs are a mixture of villous 
and extravillous cells. 
The presence of 1L-10R mRNA in human placental CTB cells has been demonstrated 
recently [129], However they have not offered any direct evidence either for the presence of 
IL-10R protein on these cells in vitro, or for placental localization of IL-10R expressing 
CTBs, in vivo. Our flow cytometric analyses clearly show the ability of CTB cells to bind 
biotin-labelled IL-10. However, freshly isolated cells which had been exposed recently to the 
proteolytic activity of trypsin during the dissociation of placental villi, as well as cultured 
cells treated with trypsin to remove them from the culture plates, failed to bind IL-10. 
Binding was only seen when the cells were incubated overnight either in solution, on agarose 
or on a rocking platform in order to prevent their attachment to the culture dish. Throughout 
culture the use of FCS which might promote both attachment and differentiation was avoided. 
Under these conditions, CTBs remained floating in the medium, but at least some of them 
formed small aggregates. Based on these observations we can not exclude the possibility that 
for the recovery of IL-10R CTBs have to make contact with each other. According to our best 
knowledge, these experiments provide the first clear-cut evidence for IL-10R expression by 
CTB cells in vitro. 
Our immunohistochemical studies demonstrate that IL-10R protein is expressed by 
early human CTBs not only in vitro, but in vivo as well. The most intense staining for 
IL-lORs occurred on the polarized villous CTB cells, and on the very proximal cells, resting 
on the basal lamina of the villous tip of CTB cell columns. The remaining invasive cells 
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stained much more weakly if at all, and villous STB did not stain. Our results also show that 
positive staining for IL-lORs and that for a« integrin subunits largely overlap. In contrast, as 
integrin expressing cells seem to be devoid of receptors for IL-10. Therefore recent findings 
[129] could be interpreted as a mechanism by which basement membrane anchored oi6 
integrin expressing CTB cells, including villous CTBs, suppress their own potentially 
invasive behaviour. It has not been clearly elucidated whether villous CTB cells produce 
gelatinases or possess gelatinase coding mRNA in vivo, but logically they have no reason to 
be invasive. The up-regulation of MMP-9 production by CTBs has been reported to occur 
after a 12 h culture period, at the time when IL-10 production of these cells is ceased. [129, 
130], Since IL-10 is a potent inhibitor of trophoblastic MMP-9 synthesis in vitro, one could 
speculate, that the gelatinase secreting activity of CTB cells starts later, when the cells escape 
from the suppressive effect of endogenous IL-10. Recent findings [129] provide the first 
clear-cut evidence for the molecular mechanism which might be responsible for this sequence 
of events in vitro, whereas our results identify the target cell population for this IL-10-
mediated autoregulatory mechanism in vivo. 
It was interesting to note that the expression pattern of IL-10R in early human 
placenta mirrors the proliferation marker Ki-67 expression reported previously [114]. 
Therefore it was tempting to speculate that IL-10 might act as an autocrine factor in 
regulating placental growth either by promoting or by inhibiting cellular proliferation within 
the human trophoblast lineages. Reports providing evidence for either the 
proliferation-promoting or the antiproliferative effect of this cytokine in other cell types were 
likely to support this hypothesis [65, 105, 137, 154, 161]. Taken together these studies 
suggest that the IL-10-dependent regulation of cellular proliferation might be 
cell-type-specific. However, signals involved by the DL-10/IL-10R system in the regulation of 
cell cycle progression that might give a comprehensive explanation for these presumably 
cell-type-specific differences are poorly understood. Since it was rather difficult to predict 
exactly how IL-10 would affect trophoblast proliferation we set out to examine the possible 
effect of IL-10 on CTB proliferation. The balance between proliferation and differentiation 
ultimately determines the structure and function of the developing placenta and is related to 
its "pseudomalignant" properties, thus the functional characterization of the IL-10/IL-10R 
system of undifferentiated CTBs as a possible autocrin/paracrin proliferation-regulating 
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factor was of particular interest for us. In accordance with previously reported data [91], our 
preliminary experiments indicated that CTB cells do not proliferate in vitro (data not shown), 
suggesting that these cells are not suited to study CTB cell proliferation at the feto-maternal 
interface. These findings indicate that either the process of tissue dissociation, when 
obtaining isolated trophoblast cells, does impair the cell or the loss of the mesodermal core of 
the placental villi as a source of growth factors is responsible for the inability of isolated CTB 
cells to proliferate ex vivo [8], Thus, the only possibility which remained was to investigate 
CTB proliferation in situ, using short term cultures of chorionic villi. The localization of 
IL-lORs on the latero-apical surface of proliferating CTB stem cells and previously reported 
works conducted on similar experimental models [100] made this experimental setting likely 
to be successful. As indicated by our immunohistochemical and immunoblotting results, 
IL-10 effectively blocked the proliferation of placental CTBs. The reversibility of this effect 
by the addition to the serum-free culture media of an IL-10R specific function-blocking 
antibody indicates that the proliferation-inhibiting effect of IL-10 was mediated through 
cell-surface IL-lORs. Ki-67 positivity of CTB nuclei in control cultures confirmed that the 
viability of our villous explants was not altered by the culture conditions. This is the first 
study showing that IL-10 is a potent inhibitor of CTB proliferation. 
The profound down-regulation of the IL-10R as soon as as integrin expression is 
turned on might suggest that IL-10 could also affect the production of the integrin family 
adhesion molecules which, in turn, impacts both CTB proliferation and invasiveness. Another 
possibility is that IL-10 might play a role in CTB differentiation. However, the possible 
involvement of IL-10 in these processes would have interesting implications from the 
perspective of the pregnancy-specific disorder preeclampsia, in which enhanced trophoblast 
proliferation, decreased invasiveness and the inadequate regulation of adhesion molecules 
have been reported [93, 163, 164], 
Near term and during parturition the effects of IL-10 are likely to be profoundly 
modulated by the pro-inflammatory mediators released in increasing concentrations by 
gestational tissues. A recent report [45] demonstrates that the basal production of MCP-1, IL-
8 and RANTES by explants of fetal membranes, decidua and placenta at term greatly exceeds 
that of IL-10. Furthermore, PGE2, which might rise near term has been able to further 
augment this basal placental production of MCP-1 and IL-8 thus promoting a local 
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inflammatory reaction and favouring parturition. PGE2 has also been shown to stimulate 
release of IL-10 by perfused placental cotyledons thereby probably enhancing local 
immunosuppression and protecting the fetal allograft during the 'high-risk' inflammatory 
process of parturition. Although the pattern of IL-10R expression by various gestational 
tissues in the late pregnancy is not yet elucidated it seems logical to suppose that, as in 
keratinocytes, the overproduced IL-8 would suppress the expression of IL-lORs by placental 
CTBs making them unresponsive to IL-10 [105], One of the multiple consequences this 
unresponsiveness might have is the possible elevation of MMP-9 production, which might 
contribute to the remodelling of the uterus and placenta in parallel with the accelerated 
growth of the fetus in the second half of pregnancy. A role favouring the separation of the 
placenta from the uterine wall after delivery is also possible. 
Therefore IL-10 appears to serve important functions throughout pregnancy as well as 
during parturition. Beside its role in placental immune protection of the fetal allograft and in 
the regulation of CTB invasiveness IL-10 seems to be involved in basic reproductive events 
such as placental growth, CTB differentiation and tissue remodelling. 
The overall conclusion of our immunohistochemical and cytological studies is that 
first trimester CTB cells express IL-lORs both in vivo and in vitro. IL-10R expression is 
localized mainly to the ct6 integrin subunit-expressing CTB cells resting on the basal lamina 
of both floating and anchoring villi, whereas differentiated trophoblasts (i.e. villous STB and 
as integrin expressing invasive cells) seem to be devoid of receptors. On the basis of our 
results we propose that one major autocrine role of IL-10 in vivo is to suppress CTB 
proliferation, thereby interfering with mechanisms of placental growth control during early 
pregnancy. Another interesting possibility is that IL-10 could suppress the invasive potential 
of basement membrane-anchored CTB cells thereby preserving their uninvasive state and/or 
might be an autocrin regulator of CTB differentiation. 
In psoriatic lesional skin the genes for proinflammatory factors as the IL8/IL-8R 
system are overexpressed [107], IL-8 is chemotactic for neutrophils [103], T lymphocytes 
[87], basophils [90] and keratinocytes [108], it stimulates neutrophil degradation and 
oxidative burst activity [148], It promotes keratinocyte proliferation [150] and induces 
HLA-DR expression in keratinocytes [79], The effects of IL-8 on keratinocytes are mediated 
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through specific receptors, which may be upregulated by IL-1 and TNF-a [74, 75], In 
lesional psoriatic epidermis IL-8R specific mRNA level was found to be 10-fold higher 
compared with the uninvolved skin [23]. Earlier results showed that several antipsoriatic 
compounds as cyclosporine, calcitriol, calcipotriol and dithranol have inhibitory effects on 
IL-8 binding to cultured keratinocytes [77, 78, 107], The IL8/IL8R system can be 
downregulated when epidermal cells are treated with the antipsoriatic drug tacrolimus 
(FK-506) in vitro [106, 136], 
IL-10 has gained increasing importance in psoriasis as a negative modulator of 
inflammatory processes [7], IL-10 was firstly described in Th2 cells and characterized by its 
ability to inhibit the typical cytokine response of Thl lymphocytes [52], Besides Th2 cells 
monocytes/macrophages, B cells, eosinophils and mast cells are able to produce IL-10 [43, 
95, 115, 140], In human skin macrophages are the main source of IL-10 [71]. The IL-10 
synthesis of keratinocytes is controversially discussed in the literature [62, 67, 118, 147]. 
IL-10 suppresses proinflammatory cytokine production and antigen-presenting capacity of 
monocytes/macrophages [43, 44, 53], dendritic cells [109], Langerhans cells [12, 49] and 
keratinocytes [10], Earlier results demonstrated that in cultured keratinocytes IFN-y induced 
HLA-DR expression is inhibited by IL-10 and it has a moderate but statistically significant 
and dose-dependent inhibitory effect on the keratinocyte growth rate [105], 
The effect of IL-10 is mediated through IL-1 OR, which shares structural homologies 
with the receptor for IFN-y [65], Previous studies showed that human keratinocytes express 
IL-10R and this expression is decreased in psoriatic epidermis [105]. 
Although HaCaT cells are frequently used in experiments investigating the effect on 
keratinocyte physiology of various drugs currently applied in the treatment of psoriatic 
patients as well as in studies concerning keratinocyte proliferation and differentiation [56, 88, 
121, 122], the expression of IL-lORs on these cells has not yet been demonstrated. Our 
immunocytochemical studies performed on subconfluent HaCaT cell cultures provide the 
first clear-cut evidence for the expression of IL-1 OR by these cells in vitro. Therefore, HaCaT 
cells are a good experimental model for the study of IL-10 induced effects on keratinocyte 
physiology. 
Dithranol is a highly effective antipsoriatic compound. Its mode of action is still not 
completely understood. Dithranol inhibits polymorphonuclear leukocyte function [135] and 
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modulates the arachidonic acid metabolism [11, 134], It has a direct inhibitory effect on 
keratinocyte proliferation [126], It is also capable of modulating cell-surface receptors of 
epidermal cells [73, 76]. 
Our immunocytochemical data also suggested that IL-10R expression is upregulated 
by HaCaT cells upon treatment with dithranol. The definitive evidence demonstrating that 
this effect of the antipsoriatic compound dithranol was due to the induction of the IL-10R 
gene was provided by the investigation of IL-10R expression at mRNA level using RT-PCR 
(these results, however, are not the subject of the present thesis). Thus, it can be concluded 
that IL-10R expression of HaCaT keratinocytes can be pharmacologically modulated. Since 
the IL-10R gene is downregulated in psoriatic epidermis [105] the pharmacological 
modulation of the receptor in our model system may be an important target in the future for 
the therapy of psoriasis. 
6 CONCLUSIONS AND PERSPECTIVES 
6.1. Developments in methods of isolation and culture of human placental trophoblast 
cells have opened a new era in the study of placental function and of the role of 
trophoblast both in the normal physiology and the pathology of human reproduction. 
As a result of these developments, rapid advances are being made in the area of 
trophoblast-endometrial interactions in implantation, reproductive immunology, 
placental endocrinology, metabolism, and pathology, trophoblast function as well as 
basic mechanisms of cell differentiation. This work reports the successful isolation 
and culture of highly purified CTB cells from normal first trimester placentae. The 
isolation of purified living placental CTB cells should allow further characterization 
of their structural, morphologic, and functional differentiation at the cellular and 
molecular level. The presented method of CTB isolation should facilitate ongoing in 
vitro studies of trophoblast adhesion, differentiation, migration, proteolytic activity, 
and invasion, and clarify how these events differ from those of malignant cells. 
Moreover, the study of adhesive interactions between trophoblast and decidual cells 
and their role in embryo implantation and development of the placenta would be a 
step toward outlining the events leading to the successful establishment and 
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maintenance of pregnancy. The elucidation of these processes may facilitate the 
further development of assisted reproductive techniques as well as of new 
contraceptive strategies. Furthermore, advances in understanding the process of 
implantation and placental development will also lend insights into clinically 
important trophoblast-related disorders of both first trimester pregnancy such as 
embryonic mortality, spontaneous abortion, abnormal placentation or gestational 
trophoblastic disease, and late pregnancy complications such as preeclampsia and/or 
intrauterine growth restriction, whose striking histopathologic feature is the 
abnormally shallow trophoblast invasion of the uterine wall, leading to placental 
maldevelopment. 
6.2. The elucidation of the role of cytokines and growth factors in the regulation of 
implantation and placentation has received considerable attention in recent years 
because placenta has proven to be a rich source of cytokines and growth factors. 
Despite considerable efforts have been made to elucidate the role of different 
cytokines in the regulation of critical reproductive events like implantation and 
placentation, the complex autocrine, paracrine and juxtacrine regulatory mechanisms 
involved are still far from being completely understood, because it is still not clear 
which cell type will respond to which cytokine. Both animal and human studies 
pointed to the importance of the Th2 cytokine IL-10 in the establishment and 
maintenance of pregnancy. As the necessary initial step in the investigation of 
cytokine function is to define the potential responsive targets by defining the cell 
populations which express relevant cytokine receptors, we have demonstrated that in 
early human placenta IL-lORs are expressed only by basement membrane anchored, 
undifferentiated CTB cells. The down-regulation of IL-10R expression which 
parallels the differentiation of these cells, as indicated by the loss of the receptor from 
differentiating cells, might indicate that, at least during early pregnancy, IL-10 might 
be important in the regulation of CTB differentiation. IL-lORs were expressed not 
only in vivo, but also in vitro, which makes isolated CTBs a useful model to study the 
role of IL-10 in trophoblast biology. 
6.3. The highly regulated balance between trophoblast proliferation and differentiation 
determines the 'pseudomalignant' characteristic of the human placenta. The presence 
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of IL-lORs on proliferating CTBs raised the possibility, that this cytokine might 
interfere with placental growth control through the autocrine regulation of CTB 
proliferation. Thus the functional analysis of IL-lORs expressed by placental CTBs 
aimed at elucidating this question. We could clearly demonstrate that IL-10 is a potent 
inhibitor of CTB proliferation. We consider that this finding is of particular 
importance especially from the perspective of the pregnancy disorder preeclampsia 
which is characterized both by a disregulation of trophoblast proliferation and a 
hyperproliferation of CTB cells associated with an abnormally shallow uterine 
invasion as a result of a seemingly defective trophoblast differentiation. Since the 
mechanisms of cell cycle control which are triggered by IL-10 seem to be 
cell-type-specific, the elucidation of these mechanisms in the particular case of CTBs 
is important not only from a general cell biological point of view, but also from the 
perspective of tumor biology. 
6.4. Whilst the trophoblast layer of chorionic villi is the epithelium which during 
intrauterine life both connects to and protects the developing conceptus from its 
milieu exterieur represented at that time by maternal blood, and the mother's immune 
system, the epidermis, the superficial epithelial layer of the skin, has a somewhat 
similar role after birth. Recently, the role of cytokines in keratinocyte biology has 
received much attention. The identification of IL-lORs on HaCaT cells opens the 
possibility to use this cell line as a model system for experiments designed to 
elucidate the role of IL-10 in keratinocyte physiology. 
6.5. Demonstrating that Dithranol upregulates IL-10R expression on HaCaT keratinocytes 
is an important step toward the elucidation of the mechanism by which this potent 
antipsoriatic compound exerts its therapeutic effect. At the same time the 
pharmacological modulation of relevant cytokine receptors in our model system may 
be an important target in the future for the therapy of psoriasis. 
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